Our CEO and co-founder, Choon-Peng (Choon) Ng recently spoke with BioSpectrum Asia about how our unique Deep Immunomics and machine learning platforms can discover and...
Oct 15, 2022
Andreas Wilm, Director of Computational Biology and Lorenz Gerber, Associate Director of Software Engineering at ImmunoScape contributed a blog post for Amazon Web...
Oct 1, 2022
ImmunoScape’s CEO Choon-Peng Ng is featured in Endpoints. Endpoints highlights ImmunoScape’s $14M funding round, our use of machine learning to discover...
Sep 14, 2022
ImmunoScape To Present at the 7th Annual CAR-TCR Summit San Diego, California and Singapore – September 14, 2022 – ImmunoScape, a pre-clinical biotechnology company...
Sep 14, 2022
ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors Anzu Partners led the $14M financing round with...
Mar 21, 2022
ImmunoScape has continued its COVID-19 collaboration with NIAID and the Johns Hopkins University. Read our paper here: Minimal Crossover between Mutations Associated...
Feb 16, 2022
SINGAPORE, SAN DIEGO, OKLAHOMA CITY, and AUSTIN – February 16, 2022 – ImmunoScape, a pre-clinical biotechnology company focused on the discovery and development of...
Jun 29, 2021
SINGAPORE and SAN DIEGO – June 29, 2021 – ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights into the human immune...
Apr 14, 2021
SINGAPORE and SAN DIEGO – April 14, 2021 – ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights into the human...